Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

331 Views

Poster Session: Antimicrobial Novel Agents

1695 - Combination Therapy for the Investigational Polymyxin SPR206 and Meropenem (MEM) Increases the Rapidity and Extent of Killing of Pseudomonas aeruginosa (PA) and Prevents the Bacterium from Emerging Resistant to Both Antibiotics

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Virtual

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Arnold Louie, MD

Professor and Associate Dir. Institute for Therapeutic Innovation
Institute for Therapeutic Innovation, University of Florida
Orlando, Florida, United States

Co-Author(s)

JB

Justin Bader, Pharm.D.

Associate Director
Spero Therapeutics
St. Augustine, Florida, United States
NC

Nicole Cotroneo, B.S.

Director
Spero Therapeutics
Cambridge, Massachusetts, United States
TL

Troy Lister, Ph.D.

Senior Vice President of Research and Development
Spero Therapeutics
Cambridge, Massachusetts, United States
WL

Weiguo Liu, M.D.

Research Scientist
Institute for Therapeutic Innovation, University of Florida
Orlando, Florida, United States
DB

David Brown, M.B.A.

Laboratory Manager
Institute for Therapeutic Innovation, University of Florida
Orlando, Florida, United States
JM

Jenny Myrick, B.S.

Medical Scientist
Institute for Therapeutic Innovation, University of Florida
Orlando, Florida, United States
GD

George Drusano, M.D.

Professor and Director, Institute for Therapeutic Innovation
Institute for Therapeutic Innovation, University of Florida
Orlando, Florida, United States